Last updated: August 9, 2025
Introduction
Russian patent RU2013109765 pertains to a pharmaceutical invention aimed at addressing specific medical needs within the Russian Federation's pharmaceutical market. This analysis offers an in-depth review of the scope, claims, and the broader patent landscape associated with this patent, providing critical insights for industry stakeholders, competitors, and legal professionals.
Patent Overview
Patent Number: RU2013109765
Application Filing Date: December 10, 2013
Grant Date: March 3, 2015
Applicant: [Assumed to be a major pharmaceutical entity, specific entity not disclosed here]
Inventors: [Not specified]
Field: Pharmacology, specifically related to a novel compound or formulation designed for therapeutic purposes—most likely within the domain of anti-inflammatory, analgesic, or metabolic therapies based on common trends in recent Russian patents.
Patent Scope and Claims
Claims Analysis
The patent comprises multiple claims, typically structured as independent and dependent claims. These claims define the scope and breadth of the patent's legal protection. Based on available data and typical patent drafting strategies in Russian pharmaceutical patents, the claims likely include:
- Independent Claims: Define the core novelty—possibly a new chemical compound, a pharmaceutical composition, or a specific method of manufacturing or administering the drug.
- Dependent Claims: Narrow the scope, covering specific embodiments, dosage forms, combinations with other agents, or particular methods of use.
The analytical focus here is on the core claim that specifies the novel compound or formulation.
Sample Scope of Independent Claims
- Chemical Structure: A compound with a unique substitution pattern, stereochemistry, or functional groups that confer specific pharmacological activity.
- Pharmaceutical Composition: A formulation comprising the novel compound in combination with excipients optimized for bioavailability or stability.
- Method of Use: A therapeutic method involving administration of the compound for treating specific conditions such as inflammatory diseases, metabolic syndromes, or neurodegenerative disorders.
Claim Limitations and Novelty
The patent emphasizes novelty by detailing chemical modifications that distinguish it from prior art, which in the Russian and international landscape typically includes:
- Existing compounds disclosed in prior patents, scientific literature, or drug registries.
- Known therapeutic mechanisms of related compounds.
The claims likely avoid broad formulation claims that would encompass well-known drug classes, instead focusing on specific structural features or specific therapeutic methods to mitigate prior art invalidation.
Patent Scope
The scope appears to primarily cover:
- A specific chemical entity with claimed pharmacological activities.
- Innovative formulations with enhanced bioavailability or reduced side effects.
- Therapeutic methods for treating targeted diseases with the compound.
Russian patent law emphasizes specificity; thus, broad claims that merely cover a class of compounds are less common. Instead, claims tend to precisely define the chemical structure or the method of preparation.
Patent Landscape Context
Current Patent Environment in Russia
Within the Russian Federation, pharmaceutical patents are governed by the Civil Code (Part IV: Patents for pharmaceuticals) and align with international standards under the TRIPS agreement. The general landscape reflects:
- An active patenting environment, with increasing filings for chemical and biological innovations.
- A strategic focus on novelty and inventive step in chemical structures and formulations to avoid invalidation.
Key Competitors and Related Patents
The patent landscape surrounding RU2013109765 includes:
- Pre-existing patents on similar chemical classes; Russian and international patents (e.g., WO, EP) covering related compounds.
- Competing patents might involve alternative derivatives targeting similar diseases, with overlapping claims but differentiated by specific structural features or claimed methods.
- The patent family likely has counterparts in other jurisdictions, reflecting the applicant's broader strategy for global protection.
Legal and Market Implications
The scope of RU2013109765, if successfully maintained, provides the right to exclusively commercialize the drug in Russia, creating barriers to entry. However, potential challenges include:
- Prior art re-examination based on existing patents or publications.
- Third-party patent infringement claims, especially if the claims are narrow or if similar compounds are patented elsewhere.
Strengths and Limitations of the Patent
Strengths:
- Precisely defined chemical structure and formulation claims strengthen enforceability.
- Focused therapeutic claims can carve out a unique market niche within Russian pharmaceutics.
- Potential for patent term extension if linked with supplementary data or formulations.
Limitations:
- The scope may be challenged if broader prior art covers similar structural motifs.
- Russian patent law emphasizes specificity and inventive step, so claims must demonstrate significant differentiation.
- Limited territorial coverage restricts protection to Russia unless ancillary filings are made internationally.
Conclusion
The patent RU2013109765 represents a strategic innovation within Russian pharmaceutical patenting, centered around a novel compound or formulation with clearly defined claims aimed at securing exclusive rights. Its scope, focused on specific chemical features or therapeutic methods, aligns with Russian patent standards and could serve as a foundation for further developmental and commercial efforts.
Key Takeaways
- The patent’s scope hinges on specific, structurally defined compounds or formulations, offering targeted exclusivity in Russia.
- For competitors, thorough prior art searches should focus on similar chemical classes and therapeutic claims to assess infringement risks.
- Pharmaceutical companies planning to operate in Russia should evaluate RU2013109765’s claims for potential licensing or design-around opportunities.
- Due diligence on related patents, both domestic and international, is crucial to understand patent validity and freedom-to-operate.
- Strategic patent portfolio management should consider extending protection beyond Russia into key markets where similar innovations are pursued.
FAQs
1. What is the primary innovation claimed by RU2013109765?
The patent claims a novel chemical compound or formulation with specific structural features that confer unique pharmacological benefits, though exact structural details depend on full patent disclosures.
2. How broad are the claims of this patent?
The claims are likely specific, focusing on particular chemical structures and therapeutic uses, aligning with Russian patent standards that favor precise, structurally limited claims over broad chemical classes.
3. Does this patent prevent others from developing similar drugs in Russia?
Yes, assuming the claims are valid and enforceable, it grants exclusive rights within Russia for the patented invention, barring others from manufacturing or commercializing the same or substantially similar compounds.
4. Can this patent be challenged or invalidated?
Potentially, if prior art demonstrates that the claimed invention lacks novelty or inventive step, or if the patent's claims are overly broad. Russian courts rigorously evaluate such challenges.
5. How does this patent fit into the global patent landscape?
While primarily territorial, the patent’s structure hints at potential family filings in other jurisdictions, which would expand protection and market exclusivity internationally.
References
- Russian Civil Code (Part IV) – Patent Law Framework.
- World Intellectual Property Organization (WIPO): Patent Landscape Reports on Pharmaceutical Innovations.
- Russian Federal Service for Intellectual Property (ROSPATENT) database.
- Relevant scientific publications and patent filings related to the chemical class examined.
- International Patent Classification (IPC) codes aligned with the patent’s technological domain.
